GENE ONLINE|News &
Opinion
Blog

2020-08-26| COVID-19Special

USFDA Chief Apologizes For Overstating Benefits of Convalescent Plasma Therapy

by Pavel Ryzhov
Share To
Following backlash from critics, FDA chief Stephen Hahn apologized for his remarks that were in agreement with the US President Donald Trump’s claim that convalescent plasma is a powerful therapy for COVID-19. The race against the clock to find a safe and efficacious treatment option against COVID-19 has been ongoing for the last 9 months. The difficulty lies not only in finding the appropriate medical intervention

GO Prime with only $1.49 now

SUBSCRIBE NOW
LATEST
BIODND – An AI-Powered Database That Breaks New Ground in Life Science Business Development
2023-11-29
GeneOnline’s Weekly News Highlights: Nov 20-Nov 24
2023-11-27
SK Bioscience and Hilleman Laboratories Join Forces for Ebola Vaccine Development
2023-11-23
BeiGene to Expand Oncology Pipeline Through ENSEM Therapeutics Partnership
2023-11-23
Advancing the Frontiers of Cell and Gene Therapy – An Interview with Dr. Shin Kawamata
2023-11-21
Astellas and Pfizer’s Drug Receives FDA Approval as Treatment for High-Risk Prostate Cancer Recurrence
2023-11-21
GeneOnline’s Weekly News Highlights: Nov 13-Nov 17
2023-11-20
READ MORE
EVENT
2023-11-30
2023 Healthcare+ EXPO・Taiwan
Taipei , Taiwan
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2023 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top